Mechanism of Action: Xanthine Oxidase Inhibitors
✉ Email this page to a colleague
Drugs with Mechanism of Action: Xanthine Oxidase Inhibitors
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Takeda Pharms Usa | ULORIC | febuxostat | TABLET;ORAL | 021856-001 | Feb 13, 2009 | AB | RX | Yes | No | 8,372,872 | ⤷ Start Trial | ⤷ Start Trial | |||
| Takeda Pharms Usa | ULORIC | febuxostat | TABLET;ORAL | 021856-002 | Feb 13, 2009 | AB | RX | Yes | Yes | 8,372,872 | ⤷ Start Trial | ⤷ Start Trial | |||
| Takeda Pharms Usa | ULORIC | febuxostat | TABLET;ORAL | 021856-002 | Feb 13, 2009 | AB | RX | Yes | Yes | 9,107,912 | ⤷ Start Trial | ⤷ Start Trial | |||
| Takeda Pharms Usa | ULORIC | febuxostat | TABLET;ORAL | 021856-001 | Feb 13, 2009 | AB | RX | Yes | No | 9,107,912 | ⤷ Start Trial | ⤷ Start Trial | |||
| Dr Reddys | LOPURIN | allopurinol | TABLET;ORAL | 071586-001 | Apr 2, 1987 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Dr Reddys | LOPURIN | allopurinol | TABLET;ORAL | 071587-001 | Apr 2, 1987 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
